Content about Lansoprazole

June 7, 2013

Skin/itch Relief 2013

The May/June 2013 Skin/itch Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of AmLactin Moisturizing Body Lotion, CeraVe Renewing SA Cream, Olay Advanced Healing, Curel Itch Defense, Vaseline Intensive Rescue, Tecnu Extreme, Benadryl ExtraStrength Spray and Allegra Anti-itch Cream.

April 4, 2013

Allergy Relief 2013

The March/April 2013 Allergy Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Claritin-D, Allegra-D, Zyrtec-D, Benadryl-D, Advil Allergy and Congestion Relief, UrgentRx Allergy Attack, Hyland's Seasonal Allergy Relief, Similasan's Nasal Allergy Relief and Boiron's Sabadil.

January 28, 2013

Vitamins & Supplements 2013

The January/February 2013 Vitamins & Supplements Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Centrum, One-A-Day, NatureMade, VitaFusion, Alive, VirMax-T, MoveFree, Bioglan and Voots products.

November 28, 2012

Cough, cold and flu

The November/December 2012 Cough, Cold and Flu Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Mucinex, Vicks, Advil, Theraflu, Delsym, St. Joseph, Hyland's Similasan and Zicam products.

October 4, 2012

Digestive Aids

The September/October 2012 Digestive Aids Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Tums, Di-Gel, Zantac, Pepcid AC, Prilosec OTC, Prevacid 24HR, Dulcolax, Senokot and Pepto-Bismol.

September 17, 2012

FDA approves Wockhardt generic ulcer drug

The Food and Drug Administration has approved a generic ulcer treatment made by Wockhardt, the Indian drug maker said Monday.

August 17, 2012

Generics contend in PPIs

Procter & Gamble’s Prilosec OTC still is the best-selling antacid on the market, with more than $252.7 million in annual sales for the 52 weeks ended July 8 across food, drug and mass (excluding Walmart), followed by fellow proton-pump inhibitor Novartis’ Prevacid 24HR ($104.1 million). 

May 21, 2012

Dr. Reddy's launches heartburn treatment

Dr. Reddy's Labs has launched a generic version of a popular over-the-counter drug for treating heartburn, the company said Monday.

May 18, 2012

Perrigo launches store-brand Prevacid 24HR

Perrigo on Friday announced that it has received final approval from the Food and Drug Administration for its abbreviated new drug application for lansoprazole capsules in the 15-mg strength.

April 23, 2012

Par buys rights to generic drug for GERD

Par Pharmaceutical has bought rights to a generic drug for gastroesophageal reflux disease from Handa Pharmaceuticals, Par said.

October 11, 2011

Antacids expect some upset

Sales of antacid tablets are up almost 3%. And while nobody is suggesting that upward trajectory is going to change anytime soon, there will be a decent amount of volatility in the coming year. 

August 17, 2011

Perrigo 2012 targets: Prevacid 24HR and Align; Lipitor on the horizon?

Perrigo is planning to launch more than 45 new products in fiscal 2012 that will translate into approximately $190 million added to annual Perrigo sales, Perrigo chairman, president and CEO Joe Papa told analysts during the company's fourth-quarter conference call Tuesday.

August 8, 2011

Digestive Aids

Breaking down OTC digestive aids by indication, active ingredients, purpose and dosage.

June 20, 2011

Three’s not a crowd: Top antacids hold their own

 Good things come in three — like the three antacids that for the 52 weeks ended April 17 collectively generated more than $118 million in sales on top of the sales base they had established in the year-ago period. 

April 18, 2011

Study: Drug-drug interaction warning letters work

A letter educating healthcare providers regarding a drug-drug interaction between prescription anticlotting drug Plavix (clopidogrel) and a proton-pump inhibitor has resulted in a reduction in the number of patients combining the two therapies, according to a new study by Prime Therapeutics released Monday.

April 5, 2011

Takeda tries to block Impax's launch of generic Dexilant

Generic drug maker Impax Labs is hoping to become the first to market a version of a gastroesophageal reflux disease treatment made by Takeda Pharmaceutical.

April 5, 2011

Takeda: Dexilant, Prevacid have less inhibiting effects on Plavix's efficacy than counterparts

Studies have indicated that proton-pump inhibitors, used for treating gastroesophageal reflux disease, reduce the efficacy of a popular blood-thinning drug, but Takeda Pharmaceuticals North America announced on Tuesday the results of a new study indicating that its own PPIs may have less of an effect.

December 22, 2010

Prilosec OTC’s ‘Heartburn gone … power on’ tagline nixed by NAD

The National Advertising Division of the Council of Better Business Bureaus on Tuesday ruled that Procter & Gamble provided reasonable support for claims that Prilosec OTC provides “superior acid control” over a competing product, Prevacid 24HR. However, the NAD recommended P&G discontinue a comparative claim made in a context that doesn’t reference acid control, the review board added.

December 7, 2010

P&G, GSK hold their own  in crowded antacid aisle

NEW YORK — Last year, the big question on everyone’s mind was: How many brands can actually thrive in what has become a cluttered antacid shelf? Because just exactly how many heartburn sufferers are there? 

November 15, 2010

Takeda launches GetToKnowGERD.com

Drug maker Takeda Pharmaceuticals is launching a campaign to raise awareness of gastroesophageal reflux disease,...

November 14, 2010

Reporters Notebook

K-V Pharmaceutical has created a new marketing subsidiary for generic drugs, the company said. K-V...

October 18, 2010

Dr. Reddy's to launch generic Prevacid

Dr. Reddy's disclosed on Tuesday it will market a generic peptic ulcer treatment....

October 17, 2010

Teva, Sandoz launch Prevacid SoluTab generics

The Food and Drug Administration granted approval for Teva's abbreviated new drug application to market...